SGLT2 Inhibitors: Cardiorenal Mechanisms How a glucose-lowering drug became a foundational heart and kidney therapy. d. 2026;4(14):28-29. Accessed July 28, 2026. https://thediabzen.com/index.php/d/article/view/54